| Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties D Ponti, A Costa, N Zaffaroni, G Pratesi, G Petrangolini, D Coradini, ... Cancer research 65 (13), 5506-5511, 2005 | 2442 | 2005 |
| The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells M Cordenonsi, F Zanconato, L Azzolin, M Forcato, A Rosato, C Frasson, ... Cell 147 (4), 759-772, 2011 | 1457 | 2011 |
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ... New England Journal of Medicine 359 (19), 1995-2004, 2008 | 1370 | 2008 |
| Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ... Cancer research 67 (19), 9142-9149, 2007 | 958 | 2007 |
| A MicroRNA targeting dicer for metastasis control G Martello, A Rosato, F Ferrari, A Manfrin, M Cordenonsi, S Dupont, ... Cell 141 (7), 1195-1207, 2010 | 821 | 2010 |
| The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients R Silvestrini, S Veneroni, MG Daidone, E Benini, P Boracchi, M Mezzetti, ... JNCI: Journal of the National Cancer Institute 86 (7), 499-504, 1994 | 620 | 1994 |
| miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cε P Gandellini, M Folini, N Longoni, M Pennati, M Binda, M Colecchia, ... Cancer research 69 (6), 2287-2295, 2009 | 435 | 2009 |
| Rational design of shepherdin, a novel anticancer agent J Plescia, W Salz, F Xia, M Pennati, N Zaffaroni, MG Daidone, M Meli, ... Cancer cell 7 (5), 457-468, 2005 | 432 | 2005 |
| Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9, 1-12, 2008 | 430 | 2008 |
| Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer N Zaffaroni, M Pennati, G Colella, P Perego, R Supino, L Gatti, S Pilotti, ... Cellular and molecular life sciences CMLS 59, 1406-1412, 2002 | 423 | 2002 |
| 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study G Bonadonna, A Moliterni, M Zambetti, MG Daidone, S Pilotti, L Gianni, ... Bmj 330 (7485), 217, 2005 | 377 | 2005 |
| p53 as an independent prognostic marker in lymph node-negative breast cancer patients R Silvestrini, E Benini, MG Daidone, S Veneroni, P Boracchi, V Cappelletti, ... JNCI: Journal of the National Cancer Institute 85 (12), 965-970, 1993 | 327 | 1993 |
| Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts S Baroni, S Romero-Cordoba, I Plantamura, M Dugo, E D’ippolito, ... Cell death & disease 7 (7), e2312-e2312, 2016 | 312 | 2016 |
| Different genetic features associated with colon and rectal carcinogenesis M Frattini, D Balestra, S Suardi, M Oggionni, P Alberici, P Radice, A Costa, ... Clinical Cancer Research 10 (12), 4015-4021, 2004 | 307 | 2004 |
| Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions N Zaffaroni, MG Daidone Drug Resistance Updates 5 (2), 65-72, 2002 | 299 | 2002 |
| Challenges in using circulating miRNAs as cancer biomarkers P Tiberio, M Callari, V Angeloni, MG Daidone, V Appierto BioMed research international 2015 (1), 731479, 2015 | 279 | 2015 |
| miR-21: an oncomir on strike in prostate cancer M Folini, P Gandellini, N Longoni, V Profumo, M Callari, M Pennati, ... Molecular cancer 9, 1-12, 2010 | 273 | 2010 |
| Cell kinetics as a prognostic marker in node‐negative breast cancer R Silvestrini, MG Daidone, G Gasparini Cancer 56 (8), 1982-1987, 1985 | 239 | 1985 |
| A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up G Martelli, P Boracchi, M De Palo, S Pilotti, S Oriana, R Zucali, ... Annals of surgery 242 (1), 1-6, 2005 | 230 | 2005 |
| Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary … F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, ... European journal of nuclear medicine 25, 1429-1434, 1998 | 218 | 1998 |
